# The Neuroprotective Effects of Alpha-Tocopherol as an Anti-Inflammatory Agent: Mechanistic Insights and Therapeutic Challenges

**Authors:** Megumi H Seese, Yuanzhong Xu

PMC · DOI: 10.3390/nu18040676 · Nutrients · 2026-02-19

## TL;DR

This paper reviews how alpha-tocopherol, a form of vitamin E, may protect the brain by reducing inflammation, but its effects depend on specific conditions.

## Contribution

The paper provides a comprehensive review of alpha-tocopherol's neuroprotective mechanisms and variability in effects based on experimental conditions.

## Key findings

- Alpha-tocopherol shows neuroprotective effects by modulating neuroinflammatory processes.
- The effectiveness of alpha-tocopherol varies with dosage, administration route, and experimental design.
- Further research is needed to optimize its therapeutic use for neuroinflammatory diseases.

## Abstract

Vitamin E (alpha-tocopherol, αToc), an antioxidant fat-soluble vitamin that prevents lipid peroxidation and modulates pro-inflammatory cytokine production, is well-known to be critical for neuroprotection. However, the underlying mechanism remains poorly understood. Accumulating evidence demonstrates that αToc influences neuroinflammatory processes. Here, we review recent research progress on the effects of αToc on neuroinflammation. Preclinical studies included in this narrative review were identified through PubMed searches using the keywords “alpha-tocopherol AND neuroinflammation or alpha-tocopherol AND brain AND inflammation”. While many studies support a neuroprotective role of αToc, the magnitude and direction of its effects vary substantially depending on dosage, route of administration, types of αToc substance, sex, and experimental design. The conclusions of this review apply only to αToc and should not be extrapolated to other vitamin E isoforms. Collectively, these findings suggest that αToc exerts beneficial effects primarily under specific conditions, and that a deeper understanding of the neural mechanisms mediating its neuroprotective actions may facilitate the optimization of therapeutic strategies for neuroinflammatory diseases.

## Linked entities

- **Chemicals:** alpha-tocopherol (PubChem CID 2116), vitamin E (PubChem CID 14985)

## Full-text entities

- **Genes:** LITAF (lipopolysaccharide induced TNF factor) [NCBI Gene 374125] {aka TNF-alpha}, Gsr (glutathione reductase) [NCBI Gene 14782] {aka D8Ertd238e, Gr-1, Gr1}, Rgn (regucalcin) [NCBI Gene 19733] {aka GNL, RC, SMP-30, SMP30}, Nr3c1 (nuclear receptor subfamily 3, group C, member 1) [NCBI Gene 14815] {aka GR, Grl-1, Grl1}, Ttpa (alpha tocopherol transfer protein) [NCBI Gene 25571] {aka TTP, alpha-TTP}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 396451] {aka CEF-147, CEF147, PGHS2, PHSII}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Cat (catalase) [NCBI Gene 12359] {aka 2210418N07, Cas-1, Cas1, Cs-1}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Prdx6-ps2 (peroxiredoxin 6 pseudogene 2) [NCBI Gene 384001] {aka Aop2-rs2, GPx*, Prdx6-rs2}, IL1B (interleukin 1, beta) [NCBI Gene 395196] {aka IL-1BETA, IL1beta}, Scarb1 (scavenger receptor class B, member 1) [NCBI Gene 25073] {aka Cd36l1, SR-B1, Srb1}, Ttpa (tocopherol (alpha) transfer protein) [NCBI Gene 50500] {aka alpha-TTP}, Il2 (interleukin 2) [NCBI Gene 16183] {aka Il-2}, Prkca (protein kinase C, alpha) [NCBI Gene 18750] {aka Pkca}, IL6 (interleukin 6) [NCBI Gene 395337] {aka CHIL-6, IL-6, interleukin-6}, Uevld (UEV and lactate/malate dehyrogenase domains) [NCBI Gene 54122] {aka 8430408E05Rik, Attp}, App (amyloid beta precursor protein) [NCBI Gene 11820] {aka Abeta, Abpp, Adap, Ag, Cvap, E030013M08Rik}
- **Diseases:** infection (MESH:D007239), Alzheimer's disease (MESH:D000544), anxiety (MESH:D001007), Neuroinflammation (MESH:D000090862), toxicity (MESH:D064420), TBI (MESH:D000070642), epilepsy (MESH:D004827), astrogliosis (MESH:D005911), arthritis (MESH:D001168), Chronic Inflammation (MESH:D007249), injury to (MESH:D014947), Neurodegenerative Disease (MESH:D019636), Parkinson's disease (MESH:D010300), seizure (MESH:D012640), chronic (MESH:D002908), tissue damage (MESH:D017695), kidney and lung damage (MESH:D007674), infarct (MESH:D007238), stroke (MESH:D020521)
- **Chemicals:** Vitamin E (MESH:D014810), nitrites (MESH:D009573), kainic acid (MESH:D007608), peroxide (MESH:D010545), omega-3 fatty acids (MESH:D015525), ropinirole (MESH:C046649), pyrethroid (MESH:D011722), MDA (MESH:D008315), oil (MESH:D009821), tocopherol (MESH:D024505), GSSG (MESH:D019803), NO (MESH:D009614), dioxins (MESH:D004147), Doxy (MESH:D004318), alpha-, gamma-, epsilon-, and delta-tocopherols (-), tocotrienols (MESH:D024508), gamma-Toc (MESH:D024504), etodolac (MESH:D017308), PUFA (MESH:D005231), ascorbic acid (MESH:D001205), alcohol (MESH:D000438), nitric oxide (MESH:D009569), ethanol (MESH:D000431), acrylamide (MESH:D020106), GSH (MESH:D005978), rotenone (MESH:D012402), phospholipids (MESH:D010743), ATP (MESH:D000255), water (MESH:D014867), lovastatin (MESH:D008148), Alpha-Tocopherol (MESH:D024502), lipid (MESH:D008055), LPS (MESH:D008070), docosahexaenoic acid (MESH:D004281)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Rodentia (rodent, order) [taxon 9989], Gallus gallus (bantam, species) [taxon 9031], Equus caballus (domestic horse, species) [taxon 9796]
- **Mutations:** G93A
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12943326/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12943326/full.md

## References

72 references — full list in the complete paper: https://tomesphere.com/paper/PMC12943326/full.md

---
Source: https://tomesphere.com/paper/PMC12943326